BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee KN, Lee OY. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. World J Gastroenterol 2014; 20(27): 8886-8897 [PMID: 25083061 DOI: 10.3748/wjg.v20.i27.8886] [Cited by in F6Publishing: 41] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Q, Zhao W, Zhao Y, Duan S, Liu WH, Zhang C, Sun S, Wang T, Wang X, Hung WL, Wang R. In vitro Study of Bifidobacterium lactis BL-99 With Fructooligosaccharide Synbiotics Effected on the Intestinal Microbiota. Front Nutr 2022;9:890316. [PMID: 35571919 DOI: 10.3389/fnut.2022.890316] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Rosa JM, Formolo DA, Yu J, Lee TH, Yau S. The Role of MicroRNA and Microbiota in Depression and Anxiety. Front Behav Neurosci 2022;16:828258. [DOI: 10.3389/fnbeh.2022.828258] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Chen M, Ruan G, Chen L, Ying S, Li G, Xu F, Xiao Z, Tian Y, Lv L, Ping Y, Cheng Y, Wei Y. Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome. Front Endocrinol 2022;13:817100. [DOI: 10.3389/fendo.2022.817100] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Rastgoo S, Ebrahimi-Daryani N, Agah S, Karimi S, Taher M, Rashidkhani B, Hejazi E, Mohseni F, Ahmadzadeh M, Sadeghi A, Hekmatdoost A. Glutamine Supplementation Enhances the Effects of a Low FODMAP Diet in Irritable Bowel Syndrome Management. Front Nutr 2021;8:746703. [PMID: 34977110 DOI: 10.3389/fnut.2021.746703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Yang J, Wang P, Liu T, Lin L, Li L, Kou G, Zhou R, Li P, Li Y. Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome. BMC Microbiol 2021;21:316. [PMID: 34773967 DOI: 10.1186/s12866-021-02380-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
6 Su Y, Tian S, Li D, Zhu W, Wang T, Mishra SK, Wei R, Xu Z, He M, Zhao X, Yin H, Fan X, Zeng B, Yang M, Yang D, Ni Q, Li Y, Zhang M, Zhu Q, Li M. Association of female reproductive tract microbiota with egg production in layer chickens. Gigascience 2021;10:giab067. [PMID: 34555848 DOI: 10.1093/gigascience/giab067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Cui J, Lin Z, Tian H, Yang B, Zhao D, Ye C, Li N, Qin H, Chen Q. Long-Term Follow-Up Results of Fecal Microbiota Transplantation for Irritable Bowel Syndrome: A Single-Center, Retrospective Study. Front Med (Lausanne) 2021;8:710452. [PMID: 34395484 DOI: 10.3389/fmed.2021.710452] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
8 Prospero L, Riezzo G, Linsalata M, Orlando A, D'Attoma B, Russo F. Psychological and Gastrointestinal Symptoms of Patients with Irritable Bowel Syndrome Undergoing a Low-FODMAP Diet: The Role of the Intestinal Barrier. Nutrients 2021;13:2469. [PMID: 34371976 DOI: 10.3390/nu13072469] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
9 Starz E, Wzorek K, Folwarski M, Kaźmierczak-Siedlecka K, Stachowska L, Przewłócka K, Stachowska E, Skonieczna-Żydecka K. The Modification of the Gut Microbiota via Selected Specific Diets in Patients with Crohn's Disease. Nutrients 2021;13:2125. [PMID: 34206152 DOI: 10.3390/nu13072125] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
10 Pitchumoni CS, Goldstein DR, Vuittonet CL. Gas, Belching, Bloating, and Flatulence: Pathogenesis, Evaluation, and Management. Geriatric Gastroenterology 2021. [DOI: 10.1007/978-3-030-30192-7_44] [Reference Citation Analysis]
11 Miryan M, Alavinejad P, Abbaspour M, Soleimani D, Ostadrahimi A. Does propolis affect the quality of life and complications in subjects with irritable bowel syndrome (diagnosed with Rome IV criteria)? A study protocol of the randomized, double-blinded, placebo-controlled clinical trial. Trials 2020;21:698. [PMID: 32758282 DOI: 10.1186/s13063-020-04615-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
12 Pitchumoni CS, Goldstein DR, Vuittonet CL. Gas, Belching, Bloating, and Flatulence: Pathogenesis, Evaluation, and Management. Geriatric Gastroenterology 2020. [DOI: 10.1007/978-3-319-90761-1_44-1] [Reference Citation Analysis]
13 Yu Q, Liu X, Huang H, Zheng X, Pan X, Fang J, Meng L, Zhou C, Zhang X, Li Z, Zou D. Mass spectrometry-based metabolomics for irritable bowel syndrome biomarkers. Therap Adv Gastroenterol 2019;12:1756284819886425. [PMID: 35154385 DOI: 10.1177/1756284819886425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Gu Y, Zhou G, Qin X, Huang S, Wang B, Cao H. The Potential Role of Gut Mycobiome in Irritable Bowel Syndrome. Front Microbiol 2019;10:1894. [PMID: 31497000 DOI: 10.3389/fmicb.2019.01894] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 9.0] [Reference Citation Analysis]
15 Тиш ОБ. Standards and risk factors for reducing the amount of lactobacillus and bifidobacterium in bronchoalveolar lavage in young patients with recurrent bronchitis. СМ 2018;0:107-110. [DOI: 10.30841/2307-5112.3.2018.147060] [Reference Citation Analysis]
16 Borgo F, Garbossa S, Riva A, Severgnini M, Luigiano C, Benetti A, Pontiroli AE, Morace G, Borghi E. Body Mass Index and Sex Affect Diverse Microbial Niches within the Gut. Front Microbiol. 2018;9:213. [PMID: 29491857 DOI: 10.3389/fmicb.2018.00213] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 10.8] [Reference Citation Analysis]
17 Shin SP, Choi YM, Kim WH, Hong SP, Park JM, Kim J, Kwon O, Lee EH, Hahm KB. A double blind, placebo-controlled, randomized clinical trial that breast milk derived-Lactobacillus gasseri BNR17 mitigated diarrhea-dominant irritable bowel syndrome. J Clin Biochem Nutr 2018;62:179-86. [PMID: 29610559 DOI: 10.3164/jcbn.17-73] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
18 He X, Cui LH, Wang XH, Yan ZH, Li C, Gong SD, Zheng Y, Luo Z, Wang Y. Modulation of inflammation by toll-like receptor 4/nuclear factor-kappa B in diarrhea-predominant irritable bowel syndrome. Oncotarget 2017;8:113957-65. [PMID: 29371960 DOI: 10.18632/oncotarget.23045] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
19 Chen Y, Xiao S, Gong Z, Zhu X, Yang Q, Li Y, Gao S, Dong Y, Shi Z, Wang Y, Weng X, Li Q, Cai W, Qiang W. Wuji Wan Formula Ameliorates Diarrhea and Disordered Colonic Motility in Post-inflammation Irritable Bowel Syndrome Rats by Modulating the Gut Microbiota. Front Microbiol 2017;8:2307. [PMID: 29218037 DOI: 10.3389/fmicb.2017.02307] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
20 Bron PA, Kleerebezem M, Brummer RJ, Cani PD, Mercenier A, MacDonald TT, Garcia-Ródenas CL, Wells JM. Can probiotics modulate human disease by impacting intestinal barrier function? Br J Nutr 2017;117:93-107. [PMID: 28102115 DOI: 10.1017/S0007114516004037] [Cited by in Crossref: 240] [Cited by in F6Publishing: 244] [Article Influence: 40.0] [Reference Citation Analysis]
21 Caputi V, Marsilio I, Cerantola S, Roozfarakh M, Lante I, Galuppini F, Rugge M, Napoli E, Giulivi C, Orso G, Giron MC. Toll-Like Receptor 4 Modulates Small Intestine Neuromuscular Function through Nitrergic and Purinergic Pathways. Front Pharmacol 2017;8:350. [PMID: 28642706 DOI: 10.3389/fphar.2017.00350] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
22 Herpertz-Dahlmann B, Seitz J, Baines J. Food matters: how the microbiome and gut-brain interaction might impact the development and course of anorexia nervosa. Eur Child Adolesc Psychiatry 2017;26:1031-41. [PMID: 28144744 DOI: 10.1007/s00787-017-0945-7] [Cited by in Crossref: 65] [Cited by in F6Publishing: 53] [Article Influence: 10.8] [Reference Citation Analysis]
23 Cayzeele-Decherf A, Pélerin F, Leuillet S, Douillard B, Housez B, Cazaubiel M, Jacobson GK, Jüsten P, Desreumaux P. Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis. World J Gastroenterol 2017; 23(2): 336-344 [PMID: 28127207 DOI: 10.3748/wjg.v23.i2.336] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
24 Almonacid DE, Kraal L, Ossandon FJ, Budovskaya YV, Cardenas JP, Richman J, Apte ZS. 16S rRNA Gene Sequencing as a Clinical Diagnostic Aid for Gastrointestinal-related Conditions.. [DOI: 10.1101/084657] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 Raskov H, Burcharth J, Pommergaard HC, Rosenberg J. Irritable bowel syndrome, the microbiota and the gut-brain axis. Gut Microbes. 2016;7:365-383. [PMID: 27472486 DOI: 10.1080/19490976.2016.1218585] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 9.1] [Reference Citation Analysis]
26 Zeber-Lubecka N, Kulecka M, Ambrozkiewicz F, Paziewska A, Goryca K, Karczmarski J, Rubel T, Wojtowicz W, Mlynarz P, Marczak L, Tomecki R, Mikula M, Ostrowski J. Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome. Gut Microbes 2016;7:397-413. [PMID: 27662586 DOI: 10.1080/19490976.2016.1215805] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
27 Wernstedt Asterholm I, Kim-Muller JY, Rutkowski JM, Crewe C, Tao C, Scherer PE. Pathological Type-2 Immune Response, Enhanced Tumor Growth, and Glucose Intolerance in Retnlβ (RELMβ) Null Mice: A Model of Intestinal Immune System Dysfunction in Disease Susceptibility. Am J Pathol 2016;186:2404-16. [PMID: 27397737 DOI: 10.1016/j.ajpath.2016.04.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
28 Ahmed I, Roy BC, Khan SA, Septer S, Umar S. Microbiome, Metabolome and Inflammatory Bowel Disease. Microorganisms. 2016;4:20. [PMID: 27681914 DOI: 10.3390/microorganisms4020020] [Cited by in Crossref: 105] [Cited by in F6Publishing: 108] [Article Influence: 15.0] [Reference Citation Analysis]
29 Han K, Wang J, Seo J, Kim H. Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial. J Gastroenterol 2017;52:432-43. [DOI: 10.1007/s00535-016-1224-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
30 Petra AI, Panagiotidou S, Hatziagelaki E, Stewart JM, Conti P, Theoharides TC. Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation. Clin Ther. 2015;37:984-995. [PMID: 26046241 DOI: 10.1016/j.clinthera.2015.04.002] [Cited by in Crossref: 325] [Cited by in F6Publishing: 349] [Article Influence: 46.4] [Reference Citation Analysis]
31 Enck P, Aziz Q, Barbara G, Farmer AD, Fukudo S, Mayer EA, Niesler B, Quigley EM, Rajilić-Stojanović M, Schemann M, Schwille-Kiuntke J, Simren M, Zipfel S, Spiller RC. Irritable bowel syndrome. Nat Rev Dis Primers 2016;2:16014. [PMID: 27159638 DOI: 10.1038/nrdp.2016.14] [Cited by in Crossref: 483] [Cited by in F6Publishing: 495] [Article Influence: 69.0] [Reference Citation Analysis]
32 Martz SL, McDonald JA, Sun J, Zhang YG, Gloor GB, Noordhof C, He SM, Gerbaba TK, Blennerhassett M, Hurlbut DJ, Allen-Vercoe E, Claud EC, Petrof EO. Administration of defined microbiota is protective in a murine Salmonella infection model. Sci Rep 2015;5:16094. [PMID: 26531327 DOI: 10.1038/srep16094] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
33 Eskesen D, Jespersen L, Michelsen B, Whorwell PJ, Müller-Lissner S, Morberg CM. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial. Br J Nutr. 2015;114:1638-1646. [PMID: 26382580 DOI: 10.1017/s0007114515003347] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.8] [Reference Citation Analysis]
34 El-Salhy M. Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol 2015; 21(25): 7621-7636 [PMID: 26167065 DOI: 10.3748/wjg.v21.i25.7621] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 68] [Article Influence: 8.4] [Reference Citation Analysis]
35 Liu HR, Fang XY, Wu HG, Wu LY, Li J, Weng ZJ, Guo XX, Li YG. Effects of electroacupuncture on corticotropin-releasing hormone in rats with chronic visceral hypersensitivity. World J Gastroenterol 2015; 21(23): 7181-7190 [PMID: 26109804 DOI: 10.3748/wjg.v21.i23.7181] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
36 Iorio N, Malik Z, Schey R. Profile of rifaximin and its potential in the treatment of irritable bowel syndrome. Clin Exp Gastroenterol 2015;8:159-67. [PMID: 26089696 DOI: 10.2147/CEG.S67231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
37 Lu XF, Zhang SS. Role of mast cells in irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2015; 23(14): 2239-2244 [DOI: 10.11569/wcjd.v23.i14.2239] [Reference Citation Analysis]
38 Gracie DJ, Ford AC. IBS-like symptoms in patients with ulcerative colitis. Clin Exp Gastroenterol. 2015;8:101-109. [PMID: 25733921 DOI: 10.2147/ceg.s58153] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
39 Rajilić-Stojanović M, Jonkers DM, Salonen A, Hanevik K, Raes J, Jalanka J, de Vos WM, Manichanh C, Golic N, Enck P, Philippou E, Iraqi FA, Clarke G, Spiller RC, Penders J. Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? Am J Gastroenterol 2015;110:278-87. [PMID: 25623659 DOI: 10.1038/ajg.2014.427] [Cited by in Crossref: 243] [Cited by in F6Publishing: 246] [Article Influence: 30.4] [Reference Citation Analysis]
40 Öhman L, Törnblom H, Simrén M. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS. Nat Rev Gastroenterol Hepatol 2015;12:36-49. [PMID: 25446728 DOI: 10.1038/nrgastro.2014.200] [Cited by in Crossref: 128] [Cited by in F6Publishing: 105] [Article Influence: 16.0] [Reference Citation Analysis]
41 Kim JW. What is the therapeutic mechanism of the probiotics in irritable bowel syndrome patients with visceral hypersensitivity? J Neurogastroenterol Motil 2014;20:555-7. [PMID: 25273125 DOI: 10.5056/jnm14100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]